After silencing the GDI2 gene, the proliferation, migration, and invasion ability of CRC cells were reduced, but the addition of the p53 pathway inhibitor restored the proliferation, migration, and invasion ability of CRC cells. This evidence concerns the gene GDI2 and colorectal carcinoma.